deoxyglucose ([14C]DG) method de pends upon quantitative trapping of metabolites in brain at the site of phosphorylation, and in the usual procedure it is assumed that all the label in plasma is in free DG. Our previous finding of labeled nonacidic derivatives of DG in plasma raised the possibility that some metabolites of DG might not be fully retained in body tissues and therefore cause overestimation of the integrated specific activity of the precursor pool determined from assay of label in plasma and/or underestimation of the true size of the me tabolite fraction in brain. In the present study, metabo lism of DG in rat tissues by secondary pathways was examined and found to be more extensive than previously recognized. When 14C-labeled compounds in ethanol ex tracts of either plasma or brain were separated by anion exchange HPLC, eight fractions were obtained. 14C_ labeled metabolites in plasma were detected after a 35min lag and gradually increased in amount with time after
an intravenous pulse. In brain, deoxyglucose-6phosphate was further metabolized, mainly to deoxyglu cose-I-phosphate and deoxyglucose-I ,6-phosphate. These are acid-labile compounds and accounted for -20% of the 14C in the metabolite pool in brain. The rate constants for net loss of 14C from the metabolite pool between 45 and 180 min after a pulse were similar (0.4-0.5%/min) in vivo and in intact postmortem brain. The rate constant for loss of deoxyglucose-6-phosphate (DG-6-P) in vivo (-0.7%/min) was, however, about twice that for postmortem brain, suggesting that a significant frac tion of the DG-6-P lost in vivo is due to its further me tabolism by energy-dependent reactions. 14C-labeled me tabolites of [14C]DG in plasma and brain do not interfere with determination of local rates of glucose utilization in brain in normal, conscious rats by the autoradiographic method if the prescribed procedures and a 45-min exper imental period are used. Key Words: Glucose-Metabolism.
(lCMRglc) in brain in vivo (Sokoloff et aI., 1977) . Modifications of the DG method are also used for determination of lCMRglc in brain slices and in cul tured neurons and astrocytes in vitro. When the 14C in tissue is quantified by autoradiography, the total level of all the labeled compounds is properly de termined, and the ultimate chemical form of the [14C]DG after its phosphorylation is irrelevant. Thus, any further metabolism of [14C]DG-6_P in brain [e .g., to glycogen (Nelson et aI., 1984) and the obligatory intermediates along the pathway to syn thesis of glycogen] does not interfere with the au to radiographic DG method . If, however, all of the metabolites of DG are not properly taken into ac count when precursor and product pools are ex tracted from brain tissue labeled in vivo or from tissue slices or cultured cells labeled in vitro and assayed by chemical methods, there can be serious errors in the determinations of lCMRgl c and the brain/plasma distribution ratios for DG. For exam ple , we recently found unidentified nonacidic, non phosphorylatable derivatives of DG in plasma and brain and acid-labile metabolites of DG in brain and showed that failure to account for these acid-labile compounds caused large overestimations of the true size of the precursor pool of e4C]DG in brain in previous studies from many laboratories that used routine perchloric acid extraction procedures to ob tain protein-free extracts of tissue (Dienel et al., 1990 (Dienel et al., , 1991 .
The presence of 1 4C-labeled metabolites of DG in plasma suggested the possibility that gradual metab olism of DG in brain and mainly other body tissues might cause loss of labeled metabolites from tissue to plasma and lead to underestimation of lCMR g lc due to overestimation of the integrated specific ac tivity of the precursor pool calculated from mea surements of 1 4C in plasma. Because free DG is cleared rapidly from plasma and tissue after an in travenous pulse, overestimation of the integrated specific activity might become significant in pro longed experimental periods, such as those in which a control and an altered functional or physiological state are sequentially assayed in the same animal with double-label procedures. Gradual metabolism of DG and DG-6-P in brain tissue or cultured cells by minor pathways might also produce derivatives that are not efficiently trapped at their site of syn thesis or do not share the same metabolic stability as DG-6-P. In the present study, we therefore ex amined the influence of labeled metabolites in plasma on calculated rates of glucose utilization in brain in vivo and assayed the stability of the major metabolites of DG in brain tissue in vivo.
MATERIALS AND METHODS
Chemicals 2-DeoxY-D-[1-14C]glucose (specific activity 49 mCil mmol) and 2-deoxY-D-[6-14Clglucose (55 mCi/mmol) were obtained from Du Pont NEN Research Products (Boston, MA, U.S.A.) and American Radiolabeled Chemicals (St. Louis, MO, U.S.A.), respectively. The radiochemical pu rity of the [14C1DG was assayed prior to use by phospho rylation with yeast hexokinase, ATP, and Mg 2 +, fol lowed by chromatographic separation of phosphorylated and unphosphorylated compounds by anion exchange HPLC as described below, and found to be >98%. Un labeled sugars used for chromatographic standards, e.g., deoxygalactose, DG, DG-6-P, glucose, 6-phosphodeoxy gluconate, D-glucose-l-phosphate, glucose-l, 6phosphate, mannitol, sorbitol, and 1,5-anhydroglucitol, and other compounds, e.g., ATP and MgCI 2 , were pur chased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). 2-Deoxysorbitol was synthesized from DG by reduction with sodium borohydride and purified as pre-J Cereb Blood Flow Metab, Vol. 13, No.2, 1993 viously described (Abdel-Akher et al., 1951) ; after the deoxysorbitol was recrystallized from methanol three times, its melting point was 106-107°C (literature value 105-106°C) (Bergmann et aI., 1923) . Hexokinase from yeast was obtained from Boehringer-Mannheim (India napolis, IN, U.S.A.)
Animals
Normal Sprague-Dawley male rats weighing 280--350 g (Taconic Farms, Germantown, NY, U.S.A.) were fed ad libitum until the day before the experiment when they were fasted overnight to stabilize plasma glucose levels. All animal use procedures were in accordance with the NIH Guide for Care and Use of Laboratory Animals and were approved by the local Animal Care Committee.
Experimental procedures
DG metabolism. On the day of the experiment, rats were catheterized with PE-50 polyethylene catheters in a femoral artery and vein under 1 % halothane170% N20 anesthesia. The rats were minimally restrained with a loose-fitting plaster cast around the lower torso, and at least 3 h was allowed for recovery prior to initiation of the experimental procedure. Body temperature was moni tored with a thermistor (Yellow Springs Instrument Co., Yellow Springs, OH, U.S.A.) and maintained at 37°C with a thermostatically controlled heating lamp. Mean ar terial blood pressure was measured with an air-damped mercury manometer, and hematocrit was determined from arterial blood samples. Arterial blood pH, P02, and Pco2 were measured with a model 158 pH Blood Gas Analyzer (Corning Medical Scientific, Medfield, MA, U.S.A.). Arterial plasma glucose and 14C contents were measured with a Glucose Analyzer II (Beckman Instru ments, Fullerton, CA, U.S.A.) and by liquid scintillation counting with external standardization, respectively. Val ues for physiological variables were similar for all groups and comparable with those usually obtained for normal conscious rats in this laboratory (Sokoloff et aI., 1977) .
Three separate groups of conscious rats were used to assay the concentrations of 14C-Iabeled metabolites of P4C1DG in plasma and brain. The first group of 35 rats was used to determine the concentrations of labeled me tabolites in plasma as a function of time and assess their possible influence on calculated ICMRg!c. Rats were given an intravenous pulse of either [1-14C1DG or [6_14C]DG (125 fLCi/kg), and killed at 45, 60, 90, 120, and 180 min. Timed arterial blood samples (-50 fL1) were drawn for analysis of the time courses of the plasma glu cose and total 14C contents. At the end of the experimen tal period, samples of arterial blood were drawn for assay of levels of [14C1DG and 14C-Iabeled metabolites in plasma, and the rats were killed with a lethal dose of pentobarbital. Their brains were quickly removed, frozen at -40 to -60°C, cut into 20-fLm coronal sections in a cryostat at -22°C, and autoradiographed together with calibrated [14Clmethylmethacrylate standards on SB5 x-ray film (Kodak, Rochester, NY, U.S.A.), as previ ously described (Sokoloff et aI., 1977) .
The other two groups of rats were used to assay levels of P4C1DG and 14C-Iabeled metabolites in brain intervals after an intravenous pulse of [1_14C]DG. Brains of the second group of 15 rats were obtained by freeze-blowing (Veech et aI., 1973) at 45, 60, 90, 120 , and 180 min after the pUlse. The third group of 20 rats was used to deter-mine postmortem changes in the concentrations of [14C]DG and 14C-Iabeled metabolites in brain. The rats were decapitated at 45 min after a pulse of [l_14C]DG, and their brains were quickly removed from the skull and bi sected along the midsagittal line. One-half of each brain was frozen in liquid nitrogen at 1.5 ± 0. 1 min after de capitation; the other half was placed in a sealed tube and incubated in a water bath at 37°C for an additional 2. 5, 7.5, 15, 30, or 45 min before being frozen in liquid nitro gen.
Determination of rates of glucose utilization. Values for lCMRg1c were calculated from plasma glucose con tents and plasma and tissue 14C levels with the opera tional equation of the [14C]DG method as previously de scribed (Sokoloff et ai., 1977) .
Extraction and assay of metabolites.
[14C]DG and 14C_ labeled metabolites were extracted from plasma and brain samples, separated by HPLC, and assayed by liquid scin tillation counting. Frozen brains were powdered under liquid N 2 in a cryostat maintained at about -35°C and divided into weighed 100-to 200-mg portions. Metabolites were extracted from portions of plasma samples and brain powders with 65% ethanol in phosphate-buffered saline as previously described (Dienel et ai., 1990) ; ethanol ex traction of brain samples is necessary to avoid degrada tion of acid-labile metabolites of DG in brain during the procedure.
Labeled metabolites were separated on a Carbo Pac PAl anion exchange column with a Dionex BioLC HPLC System equipped with a pulsed amperometric detector (Dione x Corp., Sunnyvale, CA, U.S.A.). The HPLC elu tion schedules for plasma and brain employed NaOH and sodium acetate as the eluants. Combinations of isocratic and gradient elution schedules were designed to optimize separation of sugar alcohols and monosaccharides in ex tracts of plasma (see Fig. 1 ) and of monosaccharides and their phosphorylated derivatives in extracts of brain (see Fig. 4 ). The schedule used for plasma samples was as follows: isocratic 5 mM N aOH from 0 to 30 min, followed by isocratic 100 mM NaOH from 30. 1 to 65 min, com bined with a sequential series of linear gradients of so dium acetate ranging from 150 to 200 mM from 30. 1 to 40 min, 200 to 250 mM from 40. 1 to 55 min, and 250 to 350 mM from 55. 1 to 65 min. Then the column was washed with 200 mM NaOH from 65. 1 to 75 min and regenerated with 5 mM NaOH. The schedule used for brain samples was as follows: isocratic 20 mM NaOH from 0 to 10 min, followed by isocratic 100 mM NaOH from 10.1 to 45 min, combined with a linear gradient from 150 to 450 mM so dium acetate from 10.1 to 30 min, then isocratic 500 mM sodium acetate from 30. 1 to 45 min. The column was then washed with 200 mM NaOH and regenerated with 20 mM NaOH. The CarboPac column was kept at room temper ature, and the eluant flow rate was 1 ml/min; postcolumn addition of 300 mM NaOH at a flow rate of 0.3 m1lmin was used to stabilize the baseline for detection of authen tic standards with the pulsed amperometric detector. Samples of the eluates were collected at 0.5-or I-min intervals, acidified with glacial acetic acid, and assayed for their 14C contents by liquid scintillation counting. Av erage recoveries (means ± SD) of 14C from the HPLC column were 99.6 ± 1.5% (n = 31) and 100.2 ± 3.2% (n = 16) for brain and plasma samples, respectively. Au thentic nonradioactive standards, detected with the pulsed amperometric detector, were used to calibrate elu tion times of major metabolites of DG.
RESULTS

Ethanol extraction
We previously demonstrated that the amounts of [14C]DG, 14C-Iabeled metabolites, and glucose ob tained from portions of the same plasma that were assayed in parallel before extraction and after ex traction with perchloric acid or ethanol were all equivalent (Dienel et aI ., 1990) . When recoveries from brain were tested, 95-98% of the e4C]DG and e4C]glucose added to unlabeled brain was recov ered in the ethanol extract. When brains were la beled in vivo with [14C]DG, the total 14C recovered in ethanol extracts of brain averaged -93% of that recovered in acid extracts of the same brains, whereas the recoveries of 14C-Iabeled metabolites in the ethanol and acid extracts were not statistically significantly different (Dienel et aI., 1990) . The re coveries of free DG were always higher in the acid extracts compared with ethanol extracts because of acid hydrolysis of metabolites during the extrac tion; a loss of -5% from the metabolite fraction would be difficult to detect, but would greatly in crease the size of the e4C]DG pool (Dienel et aI., 1990) . In preliminary experiments for our subse quent study (Dienel et aI ., 1991) , the ratio of total 14C recovered in ethanol extracts to that recovered from separate portions of the same brains extracted in parallel with perchloric acid averaged 0.955 ± 0.067 (mean ± SD, n = 46) for the rats given [14C]DG; similar results were obtained for 43 paired brain samples from rats given [14C]methylglucose . These rats had their plasma glucose levels clamped at predetermined levels and were given square wave infusions of [1_14C]DG or e4C]methylglucose for 45 min; the relative recoveries of 14C in ethanol extracts of brain were similar at all plasma glucose levels (range 2-27 mM) for rats given either e4C]DG or e4C]methylglucose .
C-Iabeled metabolites of DG in plasma
Separation of metabolites. 2-Deoxysorbitol and 2-deoxygalactose are two nonacidic nonphosphory latable derivatives of DG that might be formed in vivo, either by reduction of DG by aldose reductase (Hayman and Kinoshita, 1965) or by further metab olism of DG-6-P (Schmidt et al ., 1974 Druzhinina et aI ., 1975) , respectively. The HPLC elution schedule developed for plasma samples (Fig . lA) resolved fractions containing authentic deoxysorbitol, deoxygalactose, DG, and phosphor ylated sugars ( Fig. lB) . Any acidic monosaccha rides and neutral or acidic oligo saccharides in the plasma samples would have greater retention times on the Dionex anion exchange column than neutral sugars and would be eluted from the HPLC column A. Profile of NaOH/Na Acetate Elution Gradient for Dionex HPLC with CarboPac PA1 Anion Exchange Column 14C-labeled metabolites of [1_14C]DG in plasma is also shown (C). Samples of the column effluent were collected at 1-min intervals, acidified with glacial acetic acid, and assayed for their 14C contents by liquid scintillation counting. The 14C contents of HPLC fractions 1-8 were separately assayed, then pooled according to the indicated time intervals.
by 100 mM NaOH/sodium acetate gradients (Olechno et aI., 1987; Hardy and Townsend, 1988) . When plasma from a representative normoglycemic rat was sampled at 45 min after a pulse of [l_ 1 4C]DG and assayed by anion exchange HPLC, eight frac tions containing 1 4C-Iabeled compounds were sepa rated ( Fig. lC) . Almost all of the 1 4C in the extract of plasma was recovered in HPLC fraction 3; much smaller amounts were recovered in HPLC fractions 1 and 5; and trace levels of 1 4C were present in HPLC fractions 2, 4, 6, 7, and 8 ( Fig. lC) . The quantities of 1 4C recovered in all but one of the HPLC fractions, i.e., the DG fraction, were quite low; the number and identities of 1 4C-Iabeled compounds recovered in these minor fractions were therefore not determined. Authentic DG was recov ered in HPLC fraction 3 (Fig. lB) , and >97% of the 1 4C recovered in HPLC fraction 3 could be phos- 1993 phorylated by incubation with ATP, Mg 2 +, and yeast hexokinase in vitro. When the e4C]DG in ex tracts of plasma from two rats was derivatized to e4C]DG-6-P, then assayed by HPLC, the elution time of nearly all of the 1 4C that was previously recovered between 8 and 11 min was shifted to that expected for DG-6-P (i.e., �46 min; see Fig. 1 ) (re sults not shown). After removal of DG from HPLC fraction 3 by its phosphorylation, small amounts of 1 4C-Iabeled nonphosphorylatable metabolites (1 and 2.5% of the total 1 4C in the two plasma samples assayed) were recovered in the HPLC fraction con taining authentic deoxygalactose (i.e., �9 min; re sults not shown); the 1 4C recovered at 9 min was not included in the DG fraction (i.e., HPLC fraction 3).
HPLC fractions 1 and 5 contained larger amounts of 1 4C than the other minor HPLC fractions (Fig.  lC) . The elution time of the metabolite(s) recovered in HPLC fraction 1 was not altered by incubation with hexokinase (results not shown), and all four of the authentic sugar alcohol standards tested in this study, i.e. , deoxysorbitol ( Fig. lB) , sorbitol, man nitol , and 1,5-anhydroglucitol (the elution profiles of the latter three compounds are not shown in Fig.  1) , eluted from the anion exchange column between 2 and 4 min. Any [ 1 4C]deoxysorbitol present in the plasma would have been recovered in HPLC frac tion 1. Fractions 5, 6, 7, and 8 were eluted from the HPLC column by higher concentrations of the elu ants than were required to recover the alditols and monosaccharides (i.e., 100 mM NaOH/sodium ace tate gradients) ( Fig. 1B and 1C) ; these fractions may include neutral and/or acidic compounds , including oligo saccharides .
Time courses of appearance of metabolites in plasma. During the prescribed 45-min interval of the DG method, nearly all of the 1 4C in arterial plasma of conscious, normoglycemic rats was re covered as [ 1 4C]DG ( Fig. 2) . At 25, 35, and 45 min after an intravenous pulse of [l_ 1 4C]DG , 98 , 97 , and 91 %, respectively, of the 1 4C was recovered in HPLC fraction 3 (Fig. 2) . When the experimental period was extended, however, the fraction of total 1 4C recovered in the DG fraction progressively de creased to �70% at 120 min ( Fig . 2 ) and fell even further to 50 ± 4% (n = 3) at 180 min (data not shown; levels of other metabolites were not as sayed) . The labeled metabolites recovered in HPLC fractions 1 and 5 accounted for most of the 1 4C in the metabolite fractions in the plasma, i.e. , �6% at 45 min and 20% at 120 min; trace amounts of 1 4C were recovered in the other five fractions (Fig. 2) . Results (not shown) similar to those in Fig . 2 Effect of plasma metabolites on calculated glu cose utilization rate in brain. Calculated glucose utilization rates of all brain structures progressively decrease when the experimental period of the DG method exceeds 45 min after a pulse (Sokoloff , 1982; Mori et aI., 1990; Dienel et aI., 1992) . To eval uate the possibility that the influence of accumula tion of 1 4C-Iabeled metabolites in plasma (Fig. 2) is responsible for this fall in calculated ICMR g \c, rates of glucose utilization were determined for experi mental periods of 45, 60, 90, and 120 min for repre sentative structures with either a high (inferior col liculus) or a low (cerebellar white matter) metabolic rate. ICMR g \c was calculated before and after cor rections were made for the levels of 1 4C-Iabeled me tabolites in plasma . For simplification of the graph ical illustration, the results for one representative rat from each experimental group are shown in Fig.  3A , and ratios of uncorrected to the corresponding corrected rates of glucose utilization are shown in Fig . 3B . The net effect of failure to correct for plasma metabolites was a slight «6%) time-dependent underestimation of the calculated ICMR g \c at all times between 45 and 120 min. The magnitude of underestimation of ICMR g \c was sim ilar for gray and white matter structures (Fig. 3B ).
C-labeJed metabolites of DG in brain
Separation of metabolites. In addition to DG-6-P, ethanol extracts of rat brain are known to contain nonacidic , nonphosphorylatable compounds and The results are plotted as ratios of uncorrected to corrected rates of glucose utilization. Uncor rected values for ICMRglc (mean ± SO. n = 6/group) at 45, 60, 90, and 120 min, respectively, were 123. 3 ± 7.9, 113. 9 ± 4.2, 89.6 ± 5.1, and 65.0 ± 2.5 fLmol 100 g -1 min -1 for the inferior colliculus and 31.8 ± 1.9, 31.0 ± 2.0, 26.2 ± 2. 3, and 22. 7 ± 0. 9 fLmol 100 g -1 min -1 for cerebel lar white matter. acid-labile 1 4C-labeled metabolites of DG (Dienel et aI., 1990 (Dienel et aI., , 1991 . The anion exchange HPLC elution program designed for use with brain samples em ployed somewhat higher concentrations of NaOH and sodium acetate (Fig. 4A ) than those used for plasma samples (cf. Figs. 4A and 1) ; it provided good resolution for authentic standards , i.e., aldi tols , deoxysugars , glucose , and phosphorylated de rivatives of glucose and DG (Fig. 4B ). When the labeled metabolites in an ethanol extract from freeze-blown brain of a representative normoglyce mic rat were assayed, eight HPLC fractions were separated; four of these accounted for most of the 1 4C (Fig. 4C) . The major 1 4C-Iabeled metabolites recovered in HPLC fractions 2, 5, 6, and 8 were identified as DG, deoxyglucose-l-phosphate (DG-l P) , DG-6-P, and deoxyglucose-l,6-phosphate (DG-1,6-P2), respectively, on the basis of known prop- erties of these compounds (Biely et aI. , 1967; Schmidt et aI., 1974; Schwarz and Schmidt, 1976) , elution times of authentic standards , and chemical characteristics of the 1 4C-labeled compounds in these fractions [i.e., phosphorylation by hexoki nase , dephosphorylation by alkaline phosphatase , and lability to mild acid hydrolysis [1.8 M perchlo ric acid for 15 min at O°C (Dienel and Cruz, 1993) ]. DG-I-P and DG-l,6-P2 are the predominant acid labile derivatives of DG in brain. Extraction of fro zen brain powders with the routine perchloric acid procedure degraded these metabolites to DG and DG-6-P, respectively, and when acid extracts were assayed by HPLC, very little 1 4C was recovered in HPLC fractions 5 and 8 (results not shown). Levels oI14e-labeled metabolites in brain in vivo. Calculated rates of glucose utilization progressively decrease between 45 and 120 min after a pulse of thentic sugar alcohols, monosaccha rides, and sugar phosphates were cal ibrated using a pulsed amperometric detector. Note that deoxygalactose and DG were eluted earlier with 20 mM NaOH than with 5 mM NaOH (cf. Fig.   1 ). (C): Representative separation of 14C-labeled compounds in ethanol ex tracts of freeze-blown brain from a conscious, normoglycemic rat at 45 min after a pulse of [1-14C1DG. Sam ples of the column effluent were col lected at either 1-or 0.5-min (between 15 and 18 min to separate HPLC frac tions 3, 4, and 5) intervals, acidified, and assayed for their 14C contents by liquid scintillation counting. The 14C contents of HPLC fractions 1-8 were separately assayed, then pooled ac cording to the indicated time intervals. [l_ 14C]DG or [6_14C]DG, indicating that labeled me tabolites are lost from the brain (Sokoloff, 1982; Mori et aI., 1990; Dienel et al., 1992) . Because the relative stabilities of DG-6-P and other labeled me tabolites in brain tissue are not known, levels of 14C-labeled compounds were assayed in ethanol ex tracts of freeze-blown brain when the experimental period of the DG method was extended. At -45 min after a pulse of [l_14C]DG, 8% of the 14C in brain was recovered in the precursor pool as unmetabo Ii zed [l_14C]DG (Fig. 5) . e4C]DG-6-P accounted for -70% of the total 14C recovered in the total metab olite pool (i.e., the sum of ethanol-soluble and eth anol-insoluble fractions). e4C]DG-1-P and [14C]DG_ 1,6-P2 represented -6 and 13%, respectively, of the 14C in the metabolite pool (Fig . 5 ), and minor de rivatives accounted for the remainder (Dienel and Cruz, 1993) . The ethanol-insoluble compounds ac counted for -7-10% of the total 14C between 45 and 180 min (Dienel and Cruz, 1993) ; at 45 min, -20-30% of the 14C in this fraction is expected to be in glycogen [i.e., -2% of the total 14C (Nelson et al ., 1984) ]. When the duration of the experimental period was extended from 45 to 180 min, the amount of 14C in the total metabolite pool in brain gradually de creased by -50% (Fig . 5 ). Similar proportions were lost from the major HPLC fractions. The rate con stants (linear regression coefficient ± standard er ror of coefficient) for net loss of 14C from the total metabolite pool and the DG-1-P fraction (0. 0050 ± 0.0005 and 0.0054 ± 0.0005, respectively) were slightly lower, but not statistically significantly dif ferent from that for DG-6-P (0 . 0067 ± 0.0006); the 95% confidence intervals for the rate constants are 0.0016, 0.0017, and 0.0021 for total metabolites, DG-1-P, and DG-6-P, respectively. The apparent half-lives of the 14C-Iabeled metabolites were -100 min for DG-6-P and 140 min for DG-I-P and total metabolites . The actual rate of loss of DG-6-P would be somewhat greater than its net rate of loss because DG-6-P is continuously synthesized from free DG in brain after 45 min . To estimate this rate of loss, each of the measured concentrations of DG-6-P (e .g., that at 60 min) was corrected by subtract ing an estimate of the amount of DG-6-P synthe- sized from DG during the preceding experimental interval (i .e. , 45-60 min). The amount of DG-6-P synthesized was calculated as the product of the average DG concentration for each interval , the du ration of the interval , and an estimate of the weighted average rate constant for phosphorylation of DG for the heterogeneous samples of freeze blown brain [i.e. , (0 .9) (average gray matter rate constant , 0.052) + (0.1) (average white matter rate constant, 0.020) = 0.0488] . The corrected rate con stant for loss of DG-6-P was 0.0078 ± 0.005 (95% confidence interval = 0.0017; apparent half-life = 89 min). The slightly longer apparent half-life for 1 4C in the total metabolite pool compared with that for DG-6-P probably reflects further metabolism of DG-6-P to other products between 45 and 180 min. The levels of 1 4C in some of the minor fractions either remained nearly constant during between 45 and 180 min (i .e. , the ethanol-insoluble fraction and HPLC fraction 7) or even increased somewhat (HPLC fractions 3, 4, and 7) (Dienel and Cruz, 1993) . These results demonstrate that a significant fraction of the DG-6-P in brain is converted to DG- 1-P and DG-1 ,6-P2 within 45 min after a pulse, and interconversion of 1 4C among labeled metabolites continues during the time when there is net loss from the DG-6-P pool .
Postmortem changes in levels of metabolites in brain. It is commonly assumed that dephosphory lation of DG-6-P by glucose-6-phosphatase (glu cose-6-Pase) is the cause for loss of 1 4C from brain when the experimental period of the DG method exceeds 45 min . Because DG and its major metab olites can be easily separated by anion exchange HPLC , dephosphorylation of DG-6-P can be as sayed by measuring the simultaneous rates of loss of DG-6-P and formation of DG in intact brain after decapitation. In this experimental system, all me tabolites are retained in the postmortem tissue , and metabolism of DG or its metabolites by energy dependent processes is prevented. Rats were killed at 45 min after a pulse of [ 1 4C]DG; half of each brain was frozen at 1.5 min after decapitation, and the other half was incubated at 37°C for various inter vals . Most of the unmetabolized DG in brain at 45 min after the pulse was phosphorylated to DG-6-P within 1.5 min after decapitation (compare results from freeze-blown and decapitated samples; Fig . 6 ) . By this time nearly all of the ATP in brain should have been consumed (Lowry et aI ., 1964) and fur ther phosphorylation of DG by hexokinase termi nated.
During the subsequent 45 min after decapitation, the concentration of free DG slowly and progres sively increased from 2 to � 16% of the total 14C; this was accompanied by a corresponding net loss of � 15% of the 14C from the total metabolite frac tion (Fig. 6 ) . Throughout the entire postmortem pe riod, there were no changes in the 14C contents of ([1-14C10G ) and its major metabolites in brain. Separate groups of rats were killed at 45 min after a pulse of [1-14C10G by freeze-blowing (n = 3) or decapitation (n = 20). The brains obtained by decapitation were quickly removed from the skull and bisected along the midsaggital line. One half of each brain was frozen by immersion in liquid nitrogen at 1.5 ± 0.1 min (mean ± SO) after decapitation, and the other half was incubated at 3rC in a sealed tube for an additional 2.5 (n = 5), 7.5 (n = 3), 15 (n = 4), 30 (n = 4), or 45 (n = 4) min, then frozen in liquid nitrogen. Labeled metabolites in ethanol extracts of frozen brain powders were separated by HPLC (see Fig. 4 and Materials and Methods); values are means ± SO. The average (± SO) tissue 14C concentration was 380 ± 52 nCi/g for the freeze-blown samples and 322 ± 15 nCi/g for the samples obtained by decapitation.
HPLC fraction 1, indicating that aldose reductase activity did not interfere with this assay for phos phatase activity by converting [14C]DG to e4C]deoxysorbitol, which would have been recov ered in HPLC fraction 1 (results not shown). The postmortem stabilities of the major metabolites dif fered considerably. Disappearance of DG-l ,6-P 2 was most rapid, falling from about � 13 to � 3% of the total 14C between 4 and 16.5 min (Fig. 6) ; the rate constant (linear regression coefficient ± stan dard error of coefficient) for its loss during this in terval was 0.125 ± 0.001, and its apparent half-life was �6 min. During the same interval, the levels of both DG-6-P and DG rose by 4-5%; thereafter, there was net conversion of DG-6-P to DG (Fig. 6) . The ratio of the concentration of DG-I-P to that of DG-6-P was nearly constant throughout the entire postmortem period (0.062 ± 0.004, mean ± SD); the levels of both metabolites changed in parallel, prob ably due to their rapid interconversion by phospho glucomutase . The rate constant for net loss of 14C from the total metabolite pool between 2.5 and 45 min after decapitation, 0. 0043 ± 0.0003, was not statistically significantly different from that for DG-6-P between 7.5 and 45 min, 0.0034 ± 0.0004; the 95% confidence intervals for the rate constants are 0.0009 and 0.0017 , respectively . Apparent half-lives for total metabolites and DG-6-P were � 160 and 200 min, respectively . The apparent half-life of DG-6-P in postmortem tissue was about twice that in vivo; this difference was statistically significant when compared with the apparent half-life for DG-6-P in vivo (Le., �90 min, p < 0.05) obtained after cor rection for its estimated rate of resynthesis from DG between 45 and 180 min (the uncorrected value =100 min, p = 0.16).
DISCUSSION
Influence of metabolites on the routine DG method
The results of the present study demonstrate that metabolism of DG in rat tissues by secondary path ways is more extensive than generally recognized. Small quantities of many unidentified labeled com pounds were detected in plasma after a long lag time (35-45 min) . In brain, DG-6-P was the major metab olite, but two other derivatives, DG-I-P and DG-1 ,6-P2, accounted for �20% of 14C in the metabolite pool at 45 min after the pulse of DG. DG-I-P and DG-l,6-P2 have been previously found in yeast and cultured chick cells (Biely and Bauer, 1967; Schmidt et aI., 1974) but not, to our knowledge, in brain. Because glycosidic and glycosylphosphate linkages of DG are rapidly hydrolyzed by weak acid compared with those of glucose (Fischer et al., 1920; Bergmann et aI., 1922; Overend et aI., 1949; Butler et aI., 1950; Biely and Bauer, 1967; Lehle and Schwarz, 1976; Schmidt et aI., 1976) , the DG I-P and DG-l,6-P2 in frozen brain samples are de graded to DG and DG-6-P, respectively, in vitro during the usual perchloric acid extraction proce dure; other derivatives of DG that have labile gly cosidic linkages would also be degraded during acid extraction . In fact, acid hydrolysis of DG-l-P dur ing routine acid extraction of brain tissue accounts for most of the excess DG that caused overestima tion of the true size of the precursor pool for trans port and phosphorylation in brain in previous stud ies in many laboratories [see Discussion in Dienel et ai. (1990 Dienel et ai. ( , 1991 ].
The presence of labeled metabolites in plasma and secondary metabolites of DG-6-P in brain does not significantly affect determination of ICMRglc with the autoradiographic e4C]DG method when it is carried out in normal, normoglycemic, conscious rats with a 45-min experimental period as originally prescribed (Sokoloff et aI., 1977) . Significant levels of labeled metabolites of [1_14C]DG and [6_14C]DG appeared in plasma of normoglycemic rats only af ter 35 min after a pulse of DG. Overestimation of the plasma e4C]DG concentration because of la beled metabolites would cause errors in the value for the brain/plasma distribution ratio; it had, how ever, negligible effects on the integrated specific ac tivity of the precursor pool at 45 min and very small effects at 120 min «6%) that contributed negligibly to the previously observed, time-dependent decline in calculated ICMRglc (Sokoloff, 1982; Mori et aI ., 1990) . The fraction of the integrated specific activ ity due to labeled metabolites in plasma might, how ever, be higher in hypoglycemia than normoglyce mia because transport and metabolism of DG are enhanced by lowering glucose levels; this effect can be reduced by shortening the experimental period to 30 min for hypoglycemic animals (Suda et aI ., 1990) . It is unlikely that the labeled metabolites found in plasma cross the blood-brain barrier and enter the brain in amounts sufficiently high to cause significant overestimation of levels of 14C-labeled metabolites in brain. The major 14C-labeled metab olites recovered from plasma were in HPLC frac tion 1, which is probably the sugar alcohol deoxy sorbitol, and in fraction 5, which probably con tained acidic compounds or oligosaccharides . Sugar alcohols (e.g., mannitol), disaccharides, and acidic compounds do not readily cross the blood-brain barrier (Oldendorf, 1971; Ohno et aI ., 1978) . Fur thermore, DG and identified acidic metabolites syn thesized in brain accounted for nearly all of the 14C in the extracts [i.e., an average of -97, 96, 94, 93, J Cereb Blood Flow Metab, Vol. /3, No.2, 1993 and 91% at 45, 60, 90, 120, and 180 min, respec tively; most of the rest of the 14C was recovered in unidentified compounds (i .e., in HPLC fractions 3 and 4)] .
Quantitative autoradiography accounts for all 14C-labeled compounds in brain; the chemical form of the 14C-labeled metabolites (e .g., DG-6-P,6phosphodeoxygluconate, DG-I-P, DG-l,6-P2, nu cleotide sugars, glycogen, glycolipids, or glycopro teins) is irrelevant . When, however, calculated lCMRglc is based on direct measurements of precur sor and products after extraction from whole brain, brain slices, or cultured cells, the chemical proper ties of metabolites must be taken into account to prevent errors in determination of the true sizes of these pools . The magnitude of such errors will vary with time after administration of [14C]DG and with glucose level; the longer the experimental period and the lower the glucose level, the more DG is metabolized to other compounds . For example, acid extraction of brain tissue sampled at intervals after a pulse would cause a progressively larger overestimation of the e4C]DG level, reaching 1.5 to 2-fold at 45-60 min, and the level of the labeled products formed would be underestimated by at least 6% at that time due to regeneration of DG by acid hydrolysis of DG-1-P and any other glycosides of DG. Thus, rate constants for loss of products from brain in the range of 1-5%/min (Huang and Veech, 1985; Hawkins and Miller, 1987) are over estimated due, in part, to extraction of metabolites from brain with acid (Sokoloff, 1982; Nelson et aI., 1987; Dienel et aI., 1988 Dienel et aI., , 1990 ; the highest values [3-5%/min (Huang and Veech, 1985) ] were proba bly inflated further due to incomplete elution of phosphorylated metabolites of DG from Dowex-l columns with 10 ml of 4 M formic acid (Dienel et aI ., 1988) . If e4C]DG-6-P were the only metabolite as sayed in ethanol extracts, the true size of the prod uct pool would be underestimated by -30% at 45 min . Also, the nuclear magnetic resonances of the major metabolites DG-6-P, DG-I-P, and DG-l,6-P2 labeled with 19F or 31p could differ and, if not taken into account, might interfere with nuclear magnetic resonance studies employing DG to study metabo lism .
Loss of labeled metabolites when the experimental period is extended
Trapping of all labeled metabolites in the cells, where the [14C]DG is phosphorylated, throughout the duration of the experimental period is essential for accurate determination of local rates of glucose utilization in brain. Stability of 14C in the metabolite pool in brain for 45 min has been substantiated in this laboratory by demonstration of the constancy of calculated lCMRglc rates between 25 and 45 min after a pulse of DG (Sokoloff et aI., 1977; Sokoloff, 1982; Nelson et aI., 1987; Mori et aI., 1990) . When the duration of the experimental period exceeds 45-60 min, calculated lCMRglc rates decrease (Sokoloff et aI., 1982; Mori et aI., 1990; Dienel et aI., 1992) , and loss of products must be taken into account. The cause(s) for this loss has not been established. Metabolism of DG and DG-6-P in brain by alternate pathways can produce small amounts of other la beled derivatives that might eventually be lost from cells by various mechanisms, particularly when the experimental period is extended. Mechanisms for loss of 14C from brain include diffusion of DG from brain after its regeneration by hydrolysis of metab olites by phosphatases and/or glycosidases, metab olism of DG to nonacidic compounds that diffuse from brain, and decarboxylation of [1_14C]DG and loss of 14C02. Knowledge of the route(s) of loss of labeled metabolites from brain and the proportion of label lost from each pool is relevant to positron emission tomography studies that use rate con stants in their operational equation to correct for any loss of DG-6-P.
Hydrolytic reactions. It is commonly assumed, but never proven, that loss of 14C-labeled metabo lites of e4C]DG from brain is due to dephosphory lation of e4C]DG-6-P by glucose-6-Pase. Because hydrolytic reactions do not require energy, their contributions to loss of metabolites from brain might be distinguished from those of energy dependent processes by comparison of rates of net loss of labeled metabolites in vivo and in postmor tem tissue. Postmortem depletion of ATP prevents rephosphorylation of DG and blocks further energy dependent metabolism of DG-6-P without resorting to use of extremely high loads of glucose to com petitively block DG transport and phosphorylation. Because hydrolysis of DG-6-P by phosphatases should have been enhanced in postmortem tissue due to acidosis, membrane damage, and disruption of intracellular compartmentation, the twofold dif ference in the values for the apparent half-life of DG-6-P in vitro (200 min) and in vivo (90-100 min) suggests that dephosphorylation of DG-6-P by phosphatases is not the only factor governing its rate of disappearance. DG-6-P is further metabo lized to other compounds that are present in lower amounts and have different metabolic stabilities un der various conditions. For example, DG-l,6-P2 is relatively stable in vivo, but after decapitation it is degraded with a half-time of -6 min (cf. Figs. 5 and 6).
Ethanol-insoluble derivatives of e4C]DG [e.g., glycogen (Nelson et aI., 1984) and possibly oli gosaccharides and/or macromolecules Steiner et aI., 1973; Datema and Schwarz, 1978) ] accounted for -7-10% of the total 14C in the metabolite fraction between 45 and 180 min (Dienel and Cruz, 1993) . The first step in the UTP-and GTP-dependent pathways for incorpora tion of DG into macromolecules is conversion of DG-6-P to DG-l-P by phosphoglucomutase. DG-l-P and its derivatives constitute small pools of metab olites [DG-I-P is 6-7% of the level of e4C]DG-6-P (Figs. 5 and 6)] from which DG might be regener ated by various enzymes, such as a cytoplasmic galactose-I-phosphatase (Gulavita et aI., 1991) , en zyme(s) in the lumen of (liver) microsomes that de grade UDP-glucose to glucose-l-P and glucose (Perez and Hirschberg, 1986) , and glycosidases that trim protein-bound oligosaccharides (Kornfeld, 1982) . Further metabolism of DG-I-P via nucleotide sugar intermediates would terminate in postmortem brain due to depletion of A TP and might account in part for the different rates of loss of DG-6-P in vivo compared to postmortem tissue. The net rates of hydrolysis of metabolites by glucose-6-Pase, acid or alkaline phosphatases, galactose-I-phosphatase, or glycosidases were similar in vivo and in postmor tem tissue, but the contributions of any one reaction probably differed due to the energy required for en try of some of DG-6-P into small pools subsequently subject to loss. Loss of 14C from these pools might explain the long lag before the decrease in calcu lated ICMRglc rates become significant (Sokoloff et aI., 1977; Sokoloff, 1982; Nelson et aI., 1987; Mori et aI., 1990) . Further metabolism and ultimate loss of 14C from brain are not properly accounted for by correction for loss of products with one rate con stant for dephosphorylation of DG-6-P that is ap plied to the total metabolite pool.
Metabolism of DG to diffusible compounds. The rates of NADPH-dependent reduction of e4C]DG by aldose reductase in brain to produce e4C]deoxy sorbitol, a nonacidic, nonphosphorylatable metab olite, would be expected to be very low after a pulse of tracer amounts of DG because the Km for DG of hexokinase [-0.1 mM (Grossbard and Schimke, 1966) ] is much lower than that of aldose reductase for various hexoses [12-180 mM for glucose, galac tose, and mannose (Hayman and Kinoshita, 1965; Moonsammy and Stewart, 1967) ]. The negligible level [< 1 % at 45 min after a tracer dose of DG ( Fig.  4C )] of 14C found in HPLC fraction 1, which would include any deoxysorbitol, is in contrast with the larger amount of fluorodeoxysorbitol detected in brain by nuclear magnetic resonance when high loading doses of e9F]fluoro-DG (300-400 mg/kg) were given to pentobarbital-anesthetized rats (Na kada and Kwee , 1986, 1987) ; this difference proba bly reflects the Km values of these enzymes for DG, the dose of fluoro-DG, and also the influence of the functional state of the brain (i.e., conscious or anes thetized) on the rate of DG phosphorylation. Deoxysorbitol might, like sorbitol, diffuse across cell membranes (Stahl et al ., 1989) , but its loss from brain , if any, is expected to be of no consequence to the DG method because its levels are extremely low and sugar alcohols (e .g., mannitol) do not easily cross the blood-brain barrier (Oldendorf, 1971; Ohno et aI. , 1978) . Virtually all other labeled me tabolites of DG are compounds that would not dif fuse from the cell where the DG was phosphory lated.
Decarboxylation of[lJ4C]DG. [1_ 14C]DG is usu ally used to assay ICMRg\c by the [14C]DG method , and decarboxylation of [1_ 14C]DG-6-P by the pen tose phosphate shunt pathway might cause loss of 14C from brain. There is , however, no difference in the rate of loss of 1 4C from brain between 45 and 120 min after a pulse of [1_ 14C]DG or [6)4C]DG (Dienel et aI., 1992) . Thus, decarboxylation of [l_ 14C]DG-6-P by the pentose phosphate shunt pathway in adult rat brain does not interfere with the routine DG method or explain the loss of 14C with time after 45 min . Labeled plasma metabolites of [6_ 14C]DG were examined in the present study . They were found in the same HPLC fractions in similar amounts as those derived from [l_ 1 4C]DG , indicat ing that most labeled metabolites in plasma retained 14C from carbon 1 and carbon 6.
SUMMARY
In summary , the results of the present study re inforce the broad applicability of the autoradio graphic e4C]DG method to determine ICMRg\c. Un der normal , routine conditions, conversion of DG to other labeled compounds in rat brain and plasma does not interfere with the e4C]DG method as orig inally prescribed (Sokoloff et aI., 1977) . Because various amounts of DG and its major metabolite, DG-6-P, enter other metabolic pathways , particu larly when glucose levels are low , preliminary ex periments should be conducted to ensure that la beled metabolites do not interfere with use of the method under hypoglycemic or other abnormal con ditions or when experimental procedures are al tered (e .g., when extended beyond 45 min, when a loading dose of DG is administered, when a differ ent analogue of DG, such as 2-fluoro-DG, is used, or when a different species of experimental animal is used). Under conditions in which pentose shunt J Cereb Blood Flow Metab, Vol. 13, No, 2, 1993 activity might be greatly enhanced, [6_14C]DG is the precursor of choice to assay ICMRg\c. When rates of glucose utilization are determined from chemical measurements of the levels of precursor and prod ucts assayed in extracts of brain tissue labeled in vivo or in tissue slices or cultured cells labeled in vitro, postmortem artifacts must be prevented, an appropriate extraction procedure must be used, and all labeled compounds must be properly accounted for .
